Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: IPSEN BIOPHARMACEUTICALS CANADA INC
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Marketed | 02480824 | IPSEN BIOPHARMACEUTICALS CANADA INC | CABOMETYX | Human | Yes | Prescription | 1 | CABOZANTINIB (CABOZANTINIB MALATE) | 20 MG |
| Marketed | 02480832 | IPSEN BIOPHARMACEUTICALS CANADA INC | CABOMETYX | Human | Yes | Prescription | 1 | CABOZANTINIB (CABOZANTINIB MALATE) | 40 MG |
| Marketed | 02480840 | IPSEN BIOPHARMACEUTICALS CANADA INC | CABOMETYX | Human | Yes | Prescription | 1 | CABOZANTINIB (CABOZANTINIB MALATE) | 60 MG |
| Marketed | 02387735 | IPSEN BIOPHARMACEUTICALS CANADA INC | DYSPORT AESTHETIC | Human | Yes | Prescription | 1 | ABOBOTULINUMTOXINA | 300 UNIT / VIAL |
| Marketed | 02387735 | IPSEN BIOPHARMACEUTICALS CANADA INC | DYSPORT AESTHETIC | Human | Yes | Schedule D | 1 | ABOBOTULINUMTOXINA | 300 UNIT / VIAL |
| Marketed | 02456117 | IPSEN BIOPHARMACEUTICALS CANADA INC | DYSPORT THERAPEUTIC | Human | Yes | Prescription | 1 | ABOBOTULINUMTOXINA | 500 UNIT / VIAL |
| Marketed | 02456117 | IPSEN BIOPHARMACEUTICALS CANADA INC | DYSPORT THERAPEUTIC | Human | Yes | Schedule D | 1 | ABOBOTULINUMTOXINA | 500 UNIT / VIAL |
| Marketed | 02460203 | IPSEN BIOPHARMACEUTICALS CANADA INC | DYSPORT THERAPEUTIC | Human | Yes | Prescription | 1 | ABOBOTULINUMTOXINA | 300 UNIT / VIAL |
| Marketed | 02460203 | IPSEN BIOPHARMACEUTICALS CANADA INC | DYSPORT THERAPEUTIC | Human | Yes | Schedule D | 1 | ABOBOTULINUMTOXINA | 300 UNIT / VIAL |
| Marketed | 02509733 | IPSEN BIOPHARMACEUTICALS CANADA INC | INCRELEX | Human | Yes | Prescription | 1 | MECASERMIN | 40 MG / 4 ML |
| Marketed | 02509733 | IPSEN BIOPHARMACEUTICALS CANADA INC | INCRELEX | Human | Yes | Schedule D | 1 | MECASERMIN | 40 MG / 4 ML |
| Marketed | 02467135 | IPSEN BIOPHARMACEUTICALS CANADA INC | ONIVYDE | Human | Yes | Prescription | 1 | IRINOTECAN (IRINOTECAN SUCROSE OCTASULFATE) | 4.3 MG / ML |
| Marketed | 02524627 | IPSEN BIOPHARMACEUTICALS CANADA INC | SOHONOS | Human | Yes | Prescription | 1 | PALOVAROTENE | 1 MG |
| Marketed | 02524635 | IPSEN BIOPHARMACEUTICALS CANADA INC | SOHONOS | Human | Yes | Prescription | 1 | PALOVAROTENE | 1.5 MG |
| Marketed | 02524643 | IPSEN BIOPHARMACEUTICALS CANADA INC | SOHONOS | Human | Yes | Prescription | 1 | PALOVAROTENE | 2.5 MG |
| Marketed | 02524651 | IPSEN BIOPHARMACEUTICALS CANADA INC | SOHONOS | Human | Yes | Prescription | 1 | PALOVAROTENE | 5 MG |
| Marketed | 02524678 | IPSEN BIOPHARMACEUTICALS CANADA INC | SOHONOS | Human | Yes | Prescription | 1 | PALOVAROTENE | 10 MG |
| Marketed | 02283395 | IPSEN BIOPHARMACEUTICALS CANADA INC | SOMATULINE AUTOGEL | Human | Yes | Prescription | 1 | LANREOTIDE (LANREOTIDE ACETATE) | 60 MG / SYR |
| Marketed | 02283409 | IPSEN BIOPHARMACEUTICALS CANADA INC | SOMATULINE AUTOGEL | Human | Yes | Prescription | 1 | LANREOTIDE (LANREOTIDE ACETATE) | 90 MG / SYR |
| Marketed | 02283417 | IPSEN BIOPHARMACEUTICALS CANADA INC | SOMATULINE AUTOGEL | Human | Yes | Prescription | 1 | LANREOTIDE (LANREOTIDE ACETATE) | 120 MG / SYR |
Application information
Related information
Contact us
Version 4.0.2